All of following statements about are true about 6-mercaptopurine EXCEPT:
First, I need to recall the key points about 6-mercaptopurine. It's an antimetabolite, used in leukemia. It's a purine analog that inhibits purine synthesis. It's a prodrug that's converted to 6-thioguanine nucleotides, which then inhibit enzymes like IMP dehydrogenase and xanthine oxidase. It's used in acute lymphoblastic leukemia. Also, it's a component of the maintenance phase in ALL treatment.
Common side effects include myelosuppression, hepatotoxicity, and hypersensitivity reactions. It's important to note that it's a prodrug requiring activation. Also, thiopurine methyltransferase (TPMT) activity affects its metabolism; low TPMT leads to higher toxicity.
Now, considering the options, the incorrect statement would be something that's not true about 6-mercaptopurine. For example, if an option says it's a pyrimidine analog, that's wrong because it's a purine analog. Or if it's stated to be a cell cycle-specific agent, but actually it's cell cycle-nonspecific. Another incorrect point could be if it's said to be used in solid tumors, but it's mainly for leukemias.
So, the core concept here is the pharmacology and mechanism of 6-mercaptopurine. The correct answer is the one that contradicts these facts. The other options would be true statements. For each wrong option, I need to explain why they are incorrect based on known facts.
The clinical pearl would be to remember that TPMT testing is crucial before starting 6-mercaptopurine to avoid toxicity. That's a high-yield fact for exams.
Putting this all together, even without the specific options, I can structure the answer based on general knowledge. But I need to make sure that the correct answer is identified correctly. Since the user hasn't provided the options, I'll have to make assumptions based on common exam questions. For example, if one of the options states that 6-mercaptopurine is a pyrimidine analog, that's the incorrect one. So the correct answer would be that option.
**Core Concept**
6-Mercaptopurine (6-MP) is a purine analog antimetabolite used in leukemia treatment. It inhibits purine synthesis by acting as a substrate for hypoxanthine-guanine phosphoribosyltransferase (HGPRT), forming 6-thioguanine nucleotides that competitively inhibit purine metabolism enzymes. Key clinical considerations include its role in acute lymphoblastic leukemia (ALL) maintenance therapy and reliance on TPMT enzyme activity for metabolism.
**Why the Correct Answer is Right**
The correct answer is the statement contradicting 6-MPβs mechanism or clinical use. For example, if the incorrect option